MetaCap

Aclaris Therapeutics Insider Trades

NASDAQ: ACRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.44-0.06 (-1.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
1 · $1.36M
Shares bought / sold
0 / 300.00K
Net activity
Net selling $1.4 million

Aclaris Therapeutics insider activity

Over the last 12 months, Aclaris Therapeutics insiders reported 39 transactions on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $1.4 million worth of stock, for net insider selling of $1.4 million. The largest seller was Leonard Braden Michael, with $1.4 million in reported sales.

The most recent filing shows Kolbeck Roland Wilhelm (Chief Scientific Officer) reporting a transaction in 36,375 shares on Aug 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ACRS's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ACRS insider transactions

Aclaris Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Aug 1, 2026Kolbeck Roland WilhelmChief Scientific OfficerTax withholding12,385$64.40KForm 4
Aug 1, 2026Kolbeck Roland WilhelmChief Scientific OfficerOption exercise36,375—Form 4
Jun 5, 2026GOWEN MAXINEDirectorOption exercise11,580—Form 4
Jun 5, 2026MILANO VINCENTDirectorOption exercise11,580—Form 4
Jun 5, 2026Molineaux Christopher P.DirectorOption exercise11,580—Form 4
Jun 5, 2026Humphries William D.DirectorOption exercise11,580—Form 4
Jun 5, 2026Mehra AnandDirectorOption exercise11,580—Form 4
Jun 5, 2026SCHIFF ANDREW NDirectorOption exercise11,580—Form 4
May 1, 2026Hall Jesse WayneChief Medical OfficerTax withholding9,330$41.15KForm 4
May 1, 2026Hall Jesse WayneChief Medical OfficerOption exercise36,375—Form 4
Apr 23, 2026Leonard Braden Michael10% OwnerSale300,000$1.36MForm 4
Mar 1, 2026Balthaser KevinChief Financial OfficerTax withholding677$1.94KForm 4
Mar 1, 2026Balthaser KevinChief Financial OfficerOption exercise2,375—Form 4
Feb 3, 2026Davis Hugh M.President and COOOption exercise18,675—Form 4
Feb 3, 2026Walker NealCEOTax withholding18,611$64.58KForm 4
Feb 3, 2026Walker NealCEOOption exercise63,475—Form 4
Feb 3, 2026Balthaser KevinChief Financial OfficerTax withholding6,449$22.38KForm 4
Feb 3, 2026Balthaser KevinChief Financial OfficerOption exercise22,025—Form 4
Feb 3, 2026Loerop JamesChief Business OfficerTax withholding5,937$20.60KForm 4
Feb 3, 2026Loerop JamesChief Business OfficerOption exercise20,875—Form 4
Feb 1, 2026Balthaser KevinChief Financial OfficerTax withholding4,984$17.49KForm 4
Feb 1, 2026Balthaser KevinChief Financial OfficerOption exercise14,750—Form 4
Feb 1, 2026Loerop JamesChief Business OfficerTax withholding10,686$37.51KForm 4
Feb 1, 2026Loerop JamesChief Business OfficerOption exercise14,750—Form 4
Feb 1, 2026Loerop JamesChief Business OfficerOption exercise7,500—Form 4
Feb 1, 2026Loerop JamesChief Business OfficerOption exercise11,250—Form 4
Jan 2, 2026Balthaser KevinChief Financial OfficerTax withholding4,461$12.85KForm 4
Jan 2, 2026Balthaser KevinChief Financial OfficerOption exercise13,200—Form 4
Jan 2, 2026Walker NealCEOTax withholding9,952$28.66KForm 4
Jan 2, 2026Walker NealCEOOption exercise29,150—Form 4
Jan 2, 2026Loerop JamesChief Business OfficerTax withholding6,171$17.77KForm 4
Jan 2, 2026Loerop JamesChief Business OfficerOption exercise18,150—Form 4
Jan 1, 2026Balthaser KevinChief Financial OfficerTax withholding2,250$6.77KForm 4
Jan 1, 2026Balthaser KevinChief Financial OfficerOption exercise7,500—Form 4
Dec 31, 2025Balthaser KevinChief Financial OfficerTax withholding19,934$60.00KForm 4
Dec 31, 2025Balthaser KevinChief Financial OfficerOption exercise73,750—Form 4
Dec 31, 2025Loerop JamesChief Business OfficerTax withholding33,994$102.32KForm 4
Dec 31, 2025Loerop JamesChief Business OfficerOption exercise73,750—Form 4
Dec 2, 2025Davis Hugh M.President and COOOption exercise26,750—Form 4
Jun 6, 2025Molineaux Christopher P.DirectorOption exercise4,793—Form 4
Jun 6, 2025GOWEN MAXINEDirectorOption exercise4,793—Form 4
Jun 6, 2025MILANO VINCENTDirectorOption exercise4,793—Form 4
Jun 6, 2025Humphries William D.DirectorOption exercise4,793—Form 4
Jun 6, 2025Mehra AnandDirectorOption exercise4,793—Form 4
Jun 6, 2025SCHIFF ANDREW NDirectorOption exercise4,793—Form 4
May 1, 2025Walker NealCEOTax withholding2,975$4.11KForm 4
May 1, 2025Walker NealCEOOption exercise9,467—Form 4
Apr 1, 2025Walker NealCEOTax withholding3,042$4.50KForm 4
Apr 1, 2025Walker NealCEOOption exercise9,467—Form 4
Mar 1, 2025Balthaser KevinChief Financial OfficerTax withholding727$1.45KForm 4
Mar 1, 2025Balthaser KevinChief Financial OfficerOption exercise2,375—Form 4
Mar 1, 2025Balthaser KevinChief Financial OfficerOption exercise1,100—Form 4
Mar 1, 2025Walker NealCEOTax withholding3,277$6.52KForm 4
Mar 1, 2025Walker NealCEOOption exercise9,466—Form 4
Feb 1, 2025Loerop JamesChief Business OfficerTax withholding15,980$39.63KForm 4
Feb 1, 2025Loerop JamesChief Business OfficerTax withholding15,980$39.63KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related